[1]Mehrotra R, Devuyst O, Davies SJ, et al.The Current State of Peritoneal Dialysis[J].J Am Soc Nephrol, 2016, 27(11):3238-3252
[2]Wilkie M, Davies S.Insights on Peritoneal Dialysis in China[J].Perit Dial Int, 2018, 38(Suppl 2):S16-s18
[3]Hsieh YP, Chang CC, Wen YK, et al.Predictors of peritonitis and the impact of peritonitis on clinical outcomes of continuous ambulatory peritoneal dialysis patients in Taiwan--10 years' experience in a single center[J].Perit Dial Int, 2014, 34(1):85-94
[4]Miles R, Hawley CM, McDonald SP, et al.Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients[J].Kidney Int, 2009, 76(6):622-628
[5]Davenport A.Peritonitis remains the major clinical complication of peritoneal dialysis: the London,UK,peritonitis audit 2002-2003[J].Perit Dial Int, 2009, 29(3):297-302
[6]Brown MC, Simpson K, Kerssens JJ, et al.Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000-2007)[J].Perit Dial Int, 2011, 31(6):639-650
[7]Boudville N, Kemp A, Clayton P, et al.Recent peritonitis associates with mortality among patients treated with peritoneal dialysis[J].J Am Soc Nephrol, 2012, 23(8):1398-1405
[8]Pérez Fontan M, Rodríguez-Carmona A, García-Naveiro R, et al.Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis[J].Perit Dial Int, 2005, 25(3):274-284
[9]Capobianco A, Cottone L, Monno A, et al.The peritoneum: healing,immunity,and diseases[J].J Pathol, 2017, 243(2):137-147
[10]Htay H, Cho Y, Johnson DW.Longer antibiotic durations for treating peritoneal dialysis-associated peritonitis: helpful or harmful?[J].Clin Kidney J, 2021, 14(3):735-738
[11]Roubaud-Baudron C, Ruiz VE, Swan AM, Jr.Long-Term Effects of Early-Life Antibiotic Exposure on Resistance to Subsequent Bacterial Infection[J][J].mBio, 2019, 10(6):e02820-19
[12]Valour F, Karsenty J, Bouaziz A, et al.Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus[J].Antimicrob Agents Chemother, 2014, 58(2):746-755
[13]Atkins D, Eccles M, Flottorp S, et al.Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group[J].BMC Health Serv Res, 2004, 4(1):38-38
[14]Szeto CC, Kwan BC, Chow KM, et al.Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases[J].Clin J Am Soc Nephrol, 2008, 3(1):91-97
[15]Fahim M, Hawley CM, McDonald SP, et al.Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors,treatment and outcomes in 936 cases[J].Nephrol Dial Transplant, 2010, 25(10):3386-3392
[16]Edey M, Hawley CM, McDonald SP, et al.Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors,treatment and outcomes in 116 cases[J].Nephrol Dial Transplant, 2010, 25(4):1272-1278
[17]Yip T, Tse KC, Ng F, et al.Clinical course and outcomes of single-organism Enterococcus peritonitis in peritoneal dialysis patients[J].Perit Dial Int, 2011, 31(5):522-528
[18]Shukla A, Abreu Z, Bargman JM.Streptococcal PD peritonitis--a 10-year review of one centre's experience[J].Nephrol Dial Transplant, 2006, 21(12):3545-3549
[19]O' Shea S, Hawley CM, McDonald SP, et al.Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases[J]. [J].BMC Nephrol, 2009 , Jul 26(10):19-19
[20]Szeto CC, Chow KM, Chung KY, et al.The clinical course of peritoneal dialysis-related peritonitis caused by Corynebacterium species[J].Nephrol Dial Transplant, 2005, 20(12):2793-2796
[21]Barraclough K, Hawley CM, McDonald SP, et al.Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors,treatment and outcomes in 82 cases[J].Nephrol Dial Transplant, 2009, 24(12):3834-3839
[22]Htay H, Cho Y, Pascoe EM, et al.Outcomes of Corynebacterium Peritonitis: A Multicenter Registry Analysis[J].Perit Dial Int, 2017, 37(6):619-626
[23]Szeto CC, Chow KM, Kwan BC, et al.Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases[J].Clin J Am Soc Nephrol, 2007, 2(2):245-251
[24]Govindarajulu S, Hawley CM, McDonald SP, et al.Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors,treatment,and outcomes in 503 cases[J].Perit Dial Int, 2010, 30(3):311-319
[25]Fahim M, Hawley CM, McDonald SP, et al.Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors,treatment,and outcomes in 435 cases[J].Am J Kidney Dis, 2010, 55(4):690-697
[26]Barraclough K, Hawley CM, McDonald SP, et al.Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors,treatment,and outcomes[J].Am J Kidney Dis, 2010, 55(1):121-131
[27]Szeto CC, Chow KM, Leung CB, et al.Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases[J].Kidney Int, 2001, 59(6):2309-2315
[28]Siva B, Hawley CM, McDonald SP, et al.Pseudomonas peritonitis in Australia: predictors,treatment,and outcomes in 191 cases[J].Clin J Am Soc Nephrol, 2009, 4(5):957-964
[29]Lui SL, Lo CY, Choy BY, et al.Optimal treatment and long-term outcome of tuberculous peritonitis complicating continuous ambulatory peritoneal dialysis[J].Am J Kidney Dis, 1996, 28(5):747-751
[30]Lui SL, Tang S, Li FK, et al.Tuberculosis infection in Chinese patients undergoing continuous ambulatory peritoneal dialysis[J].Am J Kidney Dis, 2001, 38(5):1055-1060
[31]Szeto C-C, Ng JK-C, Wing-Shing Fung W, et al.Extended antibiotic therapy for the prevention of relapsing and recurrent peritonitis in peritoneal dialysis patients: a randomized controlled trial[J].Clinical Kidney Journal, 2021, 14(3):991-997
[32]Piraino B, Bailie GR, Bernardini J, et al.Peritoneal dialysis-related infections recommendations: 2005 update[J].Perit Dial Int, 2005, 25(2):107-131
[33]Li PK, Szeto CC, Piraino B, et al.ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment[J].Perit Dial Int, 2016, 36(5):481-508
[34]Rüger W, van Ittersum FJ, Comazzetto LF, et al.Similar peritonitis outcome in CAPD and APD patients with dialysis modality continuation during peritonitis[J].Perit Dial Int, 2011, 31(1):39-47
[35]Yang L, Gong N, Zhou H, et al.The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study?[J]. [J].Clin Nephrol, 2019, 92(1):44-51
[36]Wong SS, Ho PL, Yuen KY.Evolution of antibiotic resistance mechanisms and their relevance to dialysis-related infections[J]. [J].Perit Dial Int, 2007, 27( Suppl 2):272-280
